Treatment of endometrial cancer: Highlights from ESGO 2023

touchCONGRESS for touchONCOLOGY Listen to renowned experts in gynaecological oncology Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata review key data presented at ESGO 2023 on recent key developments in the management of patients with endometrial cancer. Aspects covered include the importance of molecular characterization and the latest clinical data for new and emerging agents, including immunotherapies and other agents, in the treatment of advanced or recurrent endometrial cancer. They also discuss how these latest developments may impact clinical practice. Overview  Data reviews with Prof. Nicole Concin Expert panel discussions with Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata on the themes below Clinical themes Molecular characterization of endometrial cancer: Latest developments  Efficacy and safety data in advanced or recurrent endometrial cancer: New and emerging immunotherapies  Efficacy and safety data in advanced or recurrent endometrial cancer: Other emerging agents  The internationally renowned expert faculty Prof. Nicole Concin: Innsbruck, Austria, Dr Mansoor Raza Mirza: Copenhagen, Denmark, Dr Sandro Pignata: Naples, Italy This touchPODCAST is for HCPs outside of the USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline, and is provided by touchIME. For further information visit our website:  https://touchoncology.com/education/expanding-horizons-in-the-treatment-of-endometrial-cancer-how-can-data-from-esgo-2023-guide-clinical-practice/#/